Caricamento...
Budesonide and fluticasone propionate differentially affect the airway epithelial barrier
BACKGROUND: COPD patients have a higher risk of pneumonia when treated with fluticasone propionate (FP) than with placebo, and a lower risk with budesonide (BUD). We hypothesized that BUD and FP differentially affect the mucosal barrier in response to viral infection and/or cigarette smoke. METHODS:...
Salvato in:
| Pubblicato in: | Respir Res |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704248/ https://ncbi.nlm.nih.gov/pubmed/26739349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0318-z |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|